Tongxun Li Selected Research

Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)

6/2013

Resveratrol reduces acute lung injury in a LPS‑induced sepsis mouse model via activation of Sirt1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tongxun Li Research Topics

Disease

2	Sepsis (Septicemia) 01/2014 - 06/2013
1	Thoracic Aortic Aneurysm 01/2022
1	Aortic Diseases 01/2022
1	Inflammation (Inflammations) 06/2013
1	Pulmonary Edema 06/2013
1	Acute Lung Injury 06/2013

Drug/Important Bio-Agent (IBA)

1	1,3,4,6- tetra- O- acetyl- 2- azido- 2- deoxyglucopyranose (TAAD)IBA 01/2022
1	Saline SolutionIBA 01/2014
1	salicylhydroxamic acid (SHAM)IBA 01/2014
1	Matrix Metalloproteinase 8 (Neutrophil Collagenase)IBA 01/2014
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2014
1	Sirtuin 1IBA 06/2013
1	ResveratrolIBA 06/2013
1	InterleukinsIBA 06/2013
1	LipopolysaccharidesIBA 06/2013
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 06/2013
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 06/2013

Therapy/Procedure

1	Ligation 01/2014
1	Punctures 01/2014
1	Intraperitoneal Injections 01/2014